Revised forecast
Fiscal year ending March 2027 · Full yearPrevious forecast published Announced in MayThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Gross profit is expected to increase by ¥110 billion, driven by Energy, Chemicals, Mobility, Digital and Infrastructure. Gains and losses related to marketable securities and fixed assets, among others, are expected to increase by ¥40 billion, driven by Innovation & Corporate Development. Equity-method investment gains and losses are expected to increase by ¥70 billion, driven by Mobility, Digital and Infrastructure, Metal Resources, and Energy. Meanwhile, selling, general and administrative expenses are expected to increase by ¥40 billion, net interest expense by ¥30 billion, and income taxes by ¥20 billion.
The disclosure mentions a partial reversal of the impairment loss on the overseas Chemicals business, but the individual amount is Not disclosed.
| Item | Details |
|---|---|
| Profit attributable to owners of the parent | ¥9,200 billion → ¥10,500 billion（+14.1%） |
| Net income per share | Not disclosed → 372.39 Yen/sen |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Full year |
| Publication date of previous forecast | Announced in May |
| Reason for the revision | Gross profit is expected to increase by ¥110 billion, driven by Energy, Chemicals, Mobility, Digital and Infrastructure. Gains and losses related to marketable securities and fixed assets, among others, are expected to increase by ¥40 billion, driven by Innovation & Corporate Development. Equity-method investment gains and losses are expected to increase by ¥70 billion, driven by Mobility, Digital and Infrastructure, Metal Resources, and Energy. Meanwhile, selling, general and administrative expenses are expected to increase by ¥40 billion, net interest expense by ¥30 billion, and income taxes by ¥20 billion. |
| Details and amount of extraordinary loss | The disclosure mentions a partial reversal of the impairment loss on the overseas Chemicals business, but the individual amount is Not disclosed. |
| Dividend forecast revision | No revision |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Gross profit is expected to increase by ¥110 billion, with contributions from Energy, Chemicals, Mobility, Digital and Infrastructure. Gains and losses related to marketable securities and fixed assets, as well as equity-method investment gains and losses, are also expected to increase, while selling, general and administrative expenses, net interest income and expense, and income taxes are expected to worsen.